Drug Profile
Mibenratide companion diagnostic - Janssen Pharmaceutica NV/Siemens Healthcare Diagnostics
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Janssen Pharmaceutica; Siemens Healthcare Diagnostics
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Heart-failure(Diagnosis) in USA
- 18 Jun 2013 Early research in Heart failure (diagnosis) in USA (unspecified route)